4.4 Review

LRRK2 regulation of immune-pathways and inflammatory disease

Journal

BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 47, Issue -, Pages 1581-1595

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BST20180463

Keywords

-

Funding

  1. Michael J. Fox Foundation for Parkinson's Research
  2. Parkinson's Foundation
  3. National Institutes of Health (NIH) [1R01NS092122, 1RF1AG057247, 1RF1AG051514]

Ask authors/readers for more resources

Mutations in the leucine-rich-repeat kinase 2 (LRRK2) gene are associated with familial and sporadic cases of Parkinson's disease but are also found in immune-related disorders such as inflammatory bowel disease, tuberculosis and leprosy. LRRK2 is highly expressed in immune cells and has been functionally linked to pathways pertinent to immune cell function, such as cytokine release, autophagy and phagocytosis. Here, we examine the current understanding of the role of LRRK2 kinase activity in pathway regulation in immune cells, drawing upon data from multiple diseases associated with LRRK2 to highlight the pleiotropic effects of LRRK2 in different cell types. We discuss the role of the bona fide LRRK2 substrate, Rab GTPases, in LRRK2 pathway regulation as well as downstream events in the autophagy and inflammatory pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available